REIPI – Spanish Network for Research in Infectious Diseases
REIPI is a Research Network aimed at improving developing high quality basic, traslational and clinical research in the area of clinical microbiology and infectious diseases
AIMS
Translation of research into clinical practice improving the outcomes of patients with Infectious Diseases
RESEARCH GROUP
17 Leading Spanish Research Groups Working in National and International Research Projects
RESEARCH PROGRAMS
Antimicrobial Resistance and Antibiotic Use Infection in Transplantation
NEWS
- REIPI’s Contribution to Advancing Drug Testing Methodologies
- How Drug-Testing Data Informs Policy on Antibiotic Stewardship
- Integrating Drug Testing into National Strategies for Combating Antimicrobial Resistance
- The Importance of Standardized Drug Testing in National Surveillance Programs
- Drug Testing in Immunocompromised Patients: Special Considerations in Transplant Recipients
NETWORK RESEARCH
REIPI is formed by 17 Spanish leading research groups in the field, and is funded by Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, co-financed by European Development Regional Fund «A way to achieve Europe» ERDF